November 29, 2019
by Transparency Market Research
According to a new report, the global dental membrane and bone graft substitutes market was valued at ~US$ 620 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.
Global Dental Membrane and Bone Graft Substitutes Market: Key Findings
Growth of the global dental membrane and bone graft substitutes market can be attributed to rise in the prevalence of dental illnesses, globally, increase in geriatric population, rise in medical tourism for dental procedures, improvement in government-initiated dental reforms, and increase in the number of dental implant procedures.
North America dominated the global dental membrane and bone graft substitutes market in 2018, and the trend is anticipated to continue during the forecast period. This can be ascribed to the presence of key players, increase in incidence of dental illnesses, and favorable reimbursement policies in the region. According to the American College of Prosthodontists (ACP), currently, 23 million people in the U.S. are completely edentulous, and another 12 million are edentulous in one arch. This is likely to drive the dental membrane and bone graft substitutes market in the U.S.
Increase in Medical Tourism for Dental Procedures to Drive Market
The number of people travelling overseas for dental procedures has been increasing over the last few years, owing to the low costs of dental procedures and superior-quality services offered to patients at various medical tourism destinations. Furthermore, the demand for dental bone graft substitutes has been rising as a domino effect, owing to rise in the popularity of medical tourism for dental implant procedures. India is one of the leading medical tourism destinations for dental bone grafting procedures, owing to the low prices and strong presence of a large number of JCI-accredited medical facilities in the country that offer superior-quality services to patients. Moreover, infrastructure in India is equipped with advanced technologies, which makes the country an ideal choice for dental medical tourism.
Increase in Number of Dental Implant Procedures to Drive Market
Implant dentistry is considered a highly attractive field, and the demand for implant dentistry among patients across the globe is high. Dental bone graft materials are largely used in dental implant procedures. Thus, increase in dental implant procedures would result in rise in the number of bone graft substitute procedures for dental implant placement and bone support in the near future. The number of dental implant procedures is increasing, due to rise in the prevalence of various dental diseases and injuries. For instance, a large number of individuals aged 65 years or above in the U.S. and Germany are edentulous. This is likely to boost the demand for dental implants in these countries during the forecast period. According to the American Academy of Implant Dentistry (2015), three million people in the U.S. have dental implants, and the number is likely to increase by 500,000 every year in the next few years.
Dental Bone Graft Products to Lead Global Market
In terms of product, the dental bone graft segment is likely to account for a major share of the global dental membrane and bone graft substitutes market. In the dental bone graft segment, the allograft sub-segment dominated the market in 2018. However, the xenograft sub-segment is likely to expand at a higher CAGR during the forecast period. This can be attributed to xenograft being a relatively less-expensive form of allograft, which does not lengthen the healing time and eliminates the need for a second surgical site for bone harvesting.
Dental Clinics to Dominate Global Market
In terms of end user, the global dental membrane and bone graft substitutes market has been divided into hospitals, dental clinics, and ambulatory surgical centers. The dental clinics segment held the largest market share in 2018, and the trend is anticipated to continue during the forecast period. Expanding geriatric patient pool and growing number of implant procedures that are leading to a surge in the number of bone graft procedures are expected to drive this segment in the near future. Also, dental clinics are preferred by patients for the treatment of various minor tooth illnesses. In addition, increase in the preference for group practice dental clinics, owing to the presence of specialist dentists and practitioners, contributes to the segment growth.
Global Dental Membrane and Bone Graft Substitutes Market: Prominent Regions
In terms of region, the global dental membrane and bone graft substitutes market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global dental membrane and bone graft substitutes market in 2018, followed by Europe. North America accounted for a major share of the global dental membrane and bone graft substitutes market in 2018. This can be attributed to the large patient pool suffering from dental disorders, favorable reimbursement policies, and presence of key players in the region.
The dental membrane and bone graft substitutes market in Asia Pacific is likely to expand at a comparatively higher CAGR from 2019 to 2027. This can be attributed to increase in the focus of market players on investing in developing countries to expand their business. This, in turn, is expected to offer immense opportunity to the market in these countries in the next few years. For instance, in October 2016, Geistlich Pharma AG established Geistlich Pharma India Pvt. Ltd., a wholly-owned subsidiary and 10th global affiliate of the firm. This strategy has enabled the company to commence its operations in India with its globally recognized products for dental regeneration, i.e. Bio-Oss and Bio-Gide, and expand its customer base.
Innovative Product Launches and Merger & Acquisition Strategies by Key Players to Drive Market
The global dental membrane and bone graft substitutes market is consolidated in terms of number of players. Key players operating in the global dental membrane and bone graft substitutes market include Institut Straumann AG, Danaher Corporation (Nobel Biocare Services AG), Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., and Osteogenics Biomedical.
These players have adopted various strategies such as product portfolio expansion, investment in research & development, and mergers & acquisitions to establish a strong geographic presence. For instance, Danaher Corporation established its strong presence in the dental membrane and bone graft substitutes market through the acquisition of 100% interest in Implant Direct in 2017 and Nobel Biocare Services AG in 2014. In July 2018, Institut Straumann AG acquired 30% stake in botiss biomaterials, a major provider of oral tissue regeneration products, based in Germany. This investment enabled the firm to strengthen its partnership, gain access to botiss’ technology, and expand its global distribution network of botiss’ products.
Follow the Oral Health Group on Facebook, Instagram, Twitter and LinkedIn for the latest updates on news, clinical articles, practice management and more!
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.